BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32357494)

  • 1. Simple Synthesis of 17-β-
    Casati S; Ottria R; Ciuffreda P
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32357494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stanozolol-N-glucuronide metabolites in human urine samples as suitable targets in terms of routine anti-doping analysis.
    Göschl L; Gmeiner G; Gärtner P; Stadler G; Enev V; Thevis M; Schänzer W; Guddat S; Forsdahl G
    Drug Test Anal; 2021 Sep; 13(9):1668-1677. PubMed ID: 34089570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in steroid screening for doping control with special emphasis on stanozolol.
    Huenerbein A; Sipoli Marques MA; Pereira Ados S; de Aquino Neto FR
    J Chromatogr A; 2003 Jan; 985(1-2):375-86. PubMed ID: 12580506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High amounts of 17-methylated anabolic-androgenic steroids in effervescent tablets on the dietary supplement market.
    Parr MK; Geyer H; Hoffmann B; Köhler K; Mareck U; Schänzer W
    Biomed Chromatogr; 2007 Feb; 21(2):164-8. PubMed ID: 17146762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis.
    Thevis M; Dib J; Thomas A; Höppner S; Lagojda A; Kuehne D; Sander M; Opfermann G; Schänzer W
    Drug Test Anal; 2015; 7(11-12):1050-6. PubMed ID: 26514814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New ELISA bulks up detection ability of steroid screening methods.
    Miller S
    Bioanalysis; 2012 Jun; 4(10):1149. PubMed ID: 22826841
    [No Abstract]   [Full Text] [Related]  

  • 7. Testing for anabolic steroids in hair from two bodybuilders.
    Kintz P; Cirimele V; Sachs H; Jeanneau T; Ludes B
    Forensic Sci Int; 1999 May; 101(3):209-16. PubMed ID: 10404632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of in vitro technologies to study the metabolism of the androgenic/anabolic steroid stanozolol in the equine.
    Scarth JP; Spencer HA; Hudson SC; Teale P; Gray BP; Hillyer LL
    Steroids; 2010 Jan; 75(1):57-69. PubMed ID: 19854209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel HPLC-MRM strategy to discover unknown and long-term metabolites of stanozolol for expanding analytical possibilities in doping-control.
    Wang Z; Zhou X; Liu X; Dong Y; Zhang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():250-259. PubMed ID: 27842983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a simple online-SPE method coupled to high-resolution mass spectrometry for the analysis of stanozolol-N-glucuronides in urine samples.
    Göschl L; Gmeiner G; Enev V; Kratena N; Gärtner P; Forsdahl G
    Drug Test Anal; 2020 Aug; 12(8):1031-1040. PubMed ID: 32302468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of anabolic steroids in human hair using LC-MS/MS.
    Deshmukh N; Hussain I; Barker J; Petroczi A; Naughton DP
    Steroids; 2010 Oct; 75(10):710-4. PubMed ID: 20435054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of stanozolol O- and N-sulfate metabolites and their evaluation as additional markers in doping control.
    Balcells G; Matabosch X; Ventura R
    Drug Test Anal; 2017 Jul; 9(7):1001-1010. PubMed ID: 27714936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approach to the preparation of hemisuccinates of steroids bearing tertiary alcohol group.
    Longin O; Černý I; Drašar P
    Steroids; 2015 May; 97():67-71. PubMed ID: 24954059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-drug interaction and doping, part 2: an in vitro study on the effect of non-prohibited drugs on the phase I metabolic profile of stanozolol.
    Mazzarino M; de la Torre X; Fiacco I; Botrè F
    Drug Test Anal; 2014 Oct; 6(10):969-77. PubMed ID: 24535830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory Effects of Diclofenac on Steroid Glucuronidation In Vivo Do Not Affect Hair-Based Doping Tests for Stanozolol.
    Zachár G; Deshmukh NIK; Petróczi A; Székely AD; Shah I; Barker J; Naughton DP
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28604639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of anabolic steroids in doping control--new steroids and new insights.
    Van Eenoo P; Delbeke FT
    J Steroid Biochem Mol Biol; 2006 Nov; 101(4-5):161-78. PubMed ID: 17000101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of mono-hydroxylated metabolites of stanozolol by HPLC-ESI (+) MS/MS in Indian sports persons.
    Ahi S; Beotra A; Jain S
    Drug Test Anal; 2009 Nov; 1(11-12):538-44. PubMed ID: 20355170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ-on-a-chip: Determine feasibility of a human liver microphysiological model to assess long-term steroid metabolites in sports drug testing.
    Görgens C; Ramme AP; Guddat S; Schrader Y; Winter A; Dehne EM; Horland R; Thevis M
    Drug Test Anal; 2021 Nov; 13(11-12):1921-1928. PubMed ID: 34505743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.